Today: 30 June 2026
Constellation Energy stock price drops 11% as $5 billion LS Power sale sharpens Calpine focus
21 March 2026
2 mins read

Constellation Energy stock price drops 11% as $5 billion LS Power sale sharpens Calpine focus

NEW YORK, March 21, 2026, 12:50 PM EDT

Constellation Energy slid 10.9% Friday to close at $281.99, erasing gains from earlier in the week. The drop followed its $5 billion PJM asset sale, and a sharp selloff hammered U.S. power stocks. Trading volume spiked: over 6.1 million shares exchanged hands versus 2.4 million the prior session. Vistra gave up 12.6%, NRG Energy was down 9.7%, and Talen Energy also lost 10.9%.

This is significant—Constellation now stands out as a top Wall Street play on surging AI data center power needs. After wrapping up its Calpine deal in January, the company’s footprint now spans nuclear, gas, and geothermal. Management is set to present its 2026 business and earnings roadmap on March 31.

The company announced Wednesday it’s offloading about 4.4 gigawatts—mostly gas-fired plants in Delaware and Pennsylvania—to LS Power. That marks the largest chunk of divestitures mandated by the U.S. Department of Justice and the Federal Energy Regulatory Commission in connection with the Calpine acquisition. CEO Joe Dominguez described the move as “an important step” toward satisfying DOJ requirements, adding that the rest of the remedies should wrap up later this year. Reuters

Constellation posted Calpine’s audited 2025 financials and the 2025 pro forma combined statements in a filing dated March 20, giving investors more merger-related details ahead of the outlook call. The company’s March 31 event is set to cover its 2026 business and earnings projections.

Timing matters here. Back in February, Reuters said PJM—the country’s biggest grid operator—was considering a plan that might nudge data center operators into striking direct agreements with independent power producers, those outfits supplying electricity to wholesale markets. James West at Melius Research was anticipating “a flurry of major data center-slash-power deals,” he told Reuters. Reuters

Zacks analyst Andrew Rocco flagged the grid’s shifting “pay-or-play” dynamic, which could push big generators like Constellation, Vistra, and Talen toward more bilateral contracting. Constellation, for its part, hasn’t waited. In February, its Calpine unit locked in a new 380-megawatt agreement with CyrusOne down in Texas, pushing the operator’s total contracted load above 1,100 MW in the state. Reuters

Meta announced earlier this year that its deal with Constellation, aimed at extending the life of an Illinois reactor by 20 years, would push the social media giant into the top tier of U.S. corporate nuclear power buyers. That agreement, set against projections for all-time high American electricity demand in 2026 and 2027, has kept Constellation’s ties to data centers firmly in the investor spotlight.

Friday’s decline, though, pointed to a market mood that’s turned sharply more cautious. The S&P 500 slid 1.51%, Reuters reported. Utilities ended up leading the laggards, sinking 4.11%. Bond yields rose, fueled by fresh jitters over inflation from rising oil prices, prompting investors to reassess expectations for rate cuts.

Company-specific risks aren’t going away. Reuters flagged that higher demand from data centers is already raising eyebrows over customer bills. And analysts pointed out, new PJM projects could easily hit bottlenecks—from permitting to state signoffs, and those notorious interconnection backlogs.

At this point, Constellation finds itself straddling two narratives: it’s got unusual 24/7 demand exposure, but it’s also a recently expanded generator navigating post-merger adjustments in a less certain economic climate. Investors get their next clear update on March 31, when management plans to lay out its 2026 strategy and earnings forecasts.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
Bitcoin Price Slides Below $70,000 After Fed Warning, Oil Spike Rattle Crypto Stocks
Previous Story

Bitcoin Price Slides Below $70,000 After Fed Warning, Oil Spike Rattle Crypto Stocks

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

US Stock Market Today: Live Updates 24.03.2026

Go toTop